- Home
- LZB vs CERT Comparison
LZB vs CERT Comparison
Compare LZB & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LZB
- CERT
- Stock Information
- Founded
- LZB 1927
- CERT 2008
- Country
- LZB United States
- CERT United States
- Employees
- LZB N/A
- CERT N/A
- Industry
- LZB Home Furnishings
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- LZB Consumer Discretionary
- CERT Technology
- Exchange
- LZB Nasdaq
- CERT Nasdaq
- Market Cap
- LZB 1.9B
- CERT 2.3B
- IPO Year
- LZB N/A
- CERT 2020
- Fundamental
- Price
- LZB $38.35
- CERT $10.43
- Analyst Decision
- LZB Hold
- CERT Buy
- Analyst Count
- LZB 1
- CERT 6
- Target Price
- LZB N/A
- CERT $15.80
- AVG Volume (30 Days)
- LZB 566.1K
- CERT 1.4M
- Earning Date
- LZB 02-18-2025
- CERT 05-06-2025
- Dividend Yield
- LZB 2.29%
- CERT N/A
- EPS Growth
- LZB 7.87
- CERT N/A
- EPS
- LZB 2.91
- CERT N/A
- Revenue
- LZB $2,091,871,000.00
- CERT $385,148,000.00
- Revenue This Year
- LZB $3.42
- CERT $11.44
- Revenue Next Year
- LZB $3.59
- CERT $8.90
- P/E Ratio
- LZB $13.64
- CERT N/A
- Revenue Growth
- LZB 1.81
- CERT 8.70
- 52 Week Low
- LZB $32.00
- CERT $9.41
- 52 Week High
- LZB $48.31
- CERT $19.22
- Technical
- Relative Strength Index (RSI)
- LZB 26.45
- CERT 24.21
- Support Level
- LZB $40.18
- CERT $10.79
- Resistance Level
- LZB $42.06
- CERT $12.27
- Average True Range (ATR)
- LZB 1.31
- CERT 0.63
- MACD
- LZB -0.59
- CERT -0.23
- Stochastic Oscillator
- LZB 2.67
- CERT 1.05
About LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; and Retail, which sells upholstered and case goods furniture to the end consumer. The majority of the company's revenue is derived from its Wholesale segment.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.